In fact, anaplastic lymphoma kinase (ALK) and downstream mutations that activate the MAPK/ERK pathway (Lopez-Delisle et al., 2018) are found in 80% of reoccurring NB tumors (Eleveld et al., 2015; Padovan-Merhar et al., 2016). Here, ALK is linked to neuroblastoma.